On November 18, 2021, Adverum Biotechnologies, Inc. informed Jack Thrift, Interim Chief Financial Officer, that his role as Adverum's Interim Chief Financial Officer, Principal Financial Officer and Principal Accounting Officer will cease in the near term, which exact date is anticipated to be in December 2021. There were no disagreements between Mr. Thrift and Adverum.